For patients co-infected with HIV, Miltefosine has demonstrated potential in Ethiopian trials, though the rise of drug resistance in endemic regions remains a concern (Ritmeijer et al., 2006)
But did you know that there are other potential benefits to GLP-1 medications
Support energy, immunity, cellular detox, and healthy skin by helping replenish the bodys master antioxidant that naturally declines with age
In the U.S., the Centers for Disease Control and Prevention reports more than 100 million adults, or about 42 percent of the population, are living with obesity, accounting for $173 billion in medical expenditures
Step 5: Follow-up care and dose adjustments Tirzepatide is started at 2.5 mg/week for four weeks, then increased in 2.5 mg increments every four weeks up to 15 mg/week based on tolerability and response